Clonogenicity, here defined as the ability for single cancer cells to generate a new colony of cells in vitro (e.g. colony formation assay) has been shown to be inhibited following suppression of BCL3 in a number of tumour types, including gastric, colorectal, breast, cervical and ovarian [13, 45, 113, 116]. Here, BCL3 is linked to cancer.